Transdermal drug delivery systems market is forecasted to cross $60 billion in size by 2023, according to P&S Market Research.
the growth in the market is expected to be driven by the surge in geriatric population, rise in number of patients suffering from neurovascular disorders and high prevalence of various chronic diseases, across the globe.
Transdermal drug delivery systems are used for various applications such as analgesics, hormone replacement therapy, hypertension, cardiovascular disorders, motion sickness, smoking cessation and others. The hormone replacement therapy category is expected to grow at a CAGR of 10% during the forecast period, since these delivery systems are effective and an easiest way of preventing and managing post-menopausal symptoms.
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/transdermal-drug-delivery-systems-market/report-sample
The use of the transdermal patches is the highest in North America, owing to heavy expenditure by the government on healthcare and supportive reimbursement policies and is further followed by the Europe and APAC, respectively. The market for transdermal drug delivery systems is expected to observe the fastest growth on demand during the forecast period in APAC. This growth in the region is attributable to the improvement in healthcare infrastructures and rise in the healthcare expenditures in developing countries such as China and India, to cater to the unmet medical needs. Further, technological advancements to develop cost-effective technologies in these nations offer a lucrative opportunity for the market growth.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=transdermal-drug-delivery-systems-market
Some of the other key players operating in the transdermal drug delivery systems industry include Acrux Limited, Bayer AG, Boehringer Ingelheim Gmbh, Bristol-Myers Squibb Company, Echo Therapeutics, Inc., Endo Pharmaceuticals Inc., Glaxosmithkline Plc, Johnson & Johnson, Mylan N.V. And Novartis Ag.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
the growth in the market is expected to be driven by the surge in geriatric population, rise in number of patients suffering from neurovascular disorders and high prevalence of various chronic diseases, across the globe.
Transdermal drug delivery systems are used for various applications such as analgesics, hormone replacement therapy, hypertension, cardiovascular disorders, motion sickness, smoking cessation and others. The hormone replacement therapy category is expected to grow at a CAGR of 10% during the forecast period, since these delivery systems are effective and an easiest way of preventing and managing post-menopausal symptoms.
Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/transdermal-drug-delivery-systems-market/report-sample
The use of the transdermal patches is the highest in North America, owing to heavy expenditure by the government on healthcare and supportive reimbursement policies and is further followed by the Europe and APAC, respectively. The market for transdermal drug delivery systems is expected to observe the fastest growth on demand during the forecast period in APAC. This growth in the region is attributable to the improvement in healthcare infrastructures and rise in the healthcare expenditures in developing countries such as China and India, to cater to the unmet medical needs. Further, technological advancements to develop cost-effective technologies in these nations offer a lucrative opportunity for the market growth.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=transdermal-drug-delivery-systems-market
Some of the other key players operating in the transdermal drug delivery systems industry include Acrux Limited, Bayer AG, Boehringer Ingelheim Gmbh, Bristol-Myers Squibb Company, Echo Therapeutics, Inc., Endo Pharmaceuticals Inc., Glaxosmithkline Plc, Johnson & Johnson, Mylan N.V. And Novartis Ag.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com